EP2841438
Pantóþenatafleiður til meðhöndlunar á taugaröskunum
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
26.4.2013EP published:
10.8.2016EP application number:
13722201.4
EP translation filed:
13.10.2016Grant published:
15.11.2016EPO information:
European Patent Register
Max expiry date:
25.4.2033Expiry date:
25.4.2020
Title:
PANTOTHENATE DERIVATIVES FOR THE TREATMENT OF NEUROLOGIC DISORDERS
Timeline
Today
26.4.2013EP application
10.8.2016EP Publication
13.10.2016Translation submitted
15.11.2016Registration published
25.4.2020Expires
Owner
Name:
Retrophin, Inc.Address:
777 Third Avenue 22nd Floor, 10017, New York, NY, US
Inventor
Name:
VAINO, AndrewAddress:
New York, NY, US
Name:
BIESTEK, MarekAddress:
New York, NY, US
Name:
SHKRELI, MartinAddress:
New York, NY, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201261639602 PDate:
27.4.2012Country:
US
Classification
Categories:
C07F 9/24, A61P 25/28, A61K 31/661
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 31.3.2017
Expires: 25.4.2018
Payer: Sigurjónsson & Thor ehf.
Number: 6
Paid: 3.4.2018
Expires: 25.4.2019
Payer: Sigurjónsson & Thor ehf.
Number: 7
Paid: 2.4.2019
Expires: 25.4.2020
Payer: Sigurjónsson & Thor ehf.